Trial intelligence / Profile preview

Topical Lidocaine for Pain Reduction in Wound Treatment

NCT03676556Phase 3Unknown

Sponsor
Bellvitge University Hospital
Start
Jun 2021
Primary completion
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of lidocaine in wound, sponsored by Bellvitge University Hospital. Status: unknown.

02

Drugs

lidocaine
03

Conditions

wound

Beyond the preview

Go deeper on NCT03676556.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03676556.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call